Eccentric Resistance Training Among Individuals With Chronic Heart Failure
Effects of Eccentric Resistance Training on Ventricle Functions and Aerobic Capacity Among Individuals With Chronic Heart Failure
1 other identifier
interventional
84
1 country
2
Brief Summary
To determine the effects of eccentric resistive training on ventricle functions and aerobic capacity as compared to a resistance and aerobic training among Heart failure (HF)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Sep 2023
Typical duration for not_applicable heart-failure
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Start
First participant enrolled
September 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedNovember 19, 2025
November 1, 2025
2.6 years
September 5, 2023
November 18, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Ventricle Functions
Changes from the baseline will be measured. Doppler resting echocardiography will be performed to measure ventricle functions. Standard views, including the parasternal long-axis, short-axis at the papillary muscle level, and apical 4- and 2-chamber views will be recorded. Left ventricular ejection fraction (LVEF) and end systolic and end-diastolic diameters (LVESD and LVEDD) will be measured using formula (Tiecholz formula i-e spherical volume of the heart multiplied by a correction factor). Any structural changes will also be recorded.
12 week
Aerobic Capacity
Changes will be measured at baseline, 4th week, 8th week and 12th week. The 6-min walk test provides an indirect measure of cardiovascular functional/aerobic capacity. Six Minute Walk test (6MWT) will be used to assess the functional capacity of the individuals with HF. The subjects will be instructed to walk for 6 minutes at a given time along a 30-m line at an interval of 1.5 m in an outdoor corridor, and the distance walked will be recorded in meters. The participants will be encouraged to continue walking as fast as possible. Then a generalized equation will be used to predict peak VO2 from 6 minute walk distance (6MWD) with the help of formula. Mean Peak VO2 (ml/kg/Mean) = 4.948 + 0.023 \*Mean 6MWD (meters)
12 week
Secondary Outcomes (9)
Quality of life (Minnesota Living with Heart Failure Questionnaire)
12 week
Strength
12 week
Maximal strength of respiratory muscles
12 week
Forced Expiratory Volume in 1 second (FEV1)
12 week
Forced vital Capacity (FVC)
12 week
- +4 more secondary outcomes
Other Outcomes (9)
Oxygen Saturation (SpO2)
12 week
Change in heart rate variability (HRV)
12 week
Modified Borg Dyspnoea Scale
12 week
- +6 more other outcomes
Study Arms (3)
Eccentric Resistive Training + Aerobic training Group
EXPERIMENTALResistance Training + Aerobic training Group
ACTIVE COMPARATORAerobic training Group
ACTIVE COMPARATORInterventions
Eccentric Resistive training includes upper limb (biceps and triceps) and lower limb large muscle training (quadriceps and hamstrings) 2 sets of 12 repetitions (reps) for each group of muscles in lengthened position for eccentric training in approx. 20 minutes (min). Intensity will be based on 1 repetition maximum (1RM) starting from 20% of (1RM) and its intensity in percentage will be progress by 10% after every two weeks. Stair descending training and squatting position and eccentric hamstring curls with weights at ankle for lower limb eccentric training progressive as per tolerance in response to modified Borg scale (with cut off of showing dyspnea of 4 somewhat hard) and Numeric Pain rating scale (with cut off of showing 7 on scale, crossing moderate pain) . (approx. 20 min). \+ Aerobic training as a control will be given to this group as well for approximately 30 minutes per session.
Resistive training (concentric) includes Upper limb (biceps and triceps) and lower limb large muscle training (quadriceps and hamstrings), 2 sets of 12 reps for each group of muscles in approx. 30 min. Intensity will be based on 1 repetition maximum (1RM) starting from 20% of (1RM) and its intensity in percentage will be progress by 10% after every two weeks. Stair climbing training and quadriceps training + standing hamstring curls with weight at ankle for lower limb concentric training progressive as per tolerance in response to modified Borg scale (with cut off of showing dyspnea of 4 somewhat hard) and Numeric Pain rating scale (with cut off of showing 7 on scale, crossing moderate pain) \+ Aerobic training as a control will be given to this group as well for approximately 30 minutes per session.
Aerobic training as a control will be given to this group as well for approximately 60 minutes per session. Aerobic training exercise will be completed via a ergometer/stationary cycle; type will be continuous aerobic exercise and intensity of 60% of max HR (or peak VO2) in HF individuals.
Eligibility Criteria
You may qualify if:
- Diagnosis of Chronic HF and currently stable with optimal medical therapy
- Chronic Heart failure with ejection fraction \> 30 %
- Patient able to safely perform lower limb exercise will be check by six- minute walk test (6 MWT)
You may not qualify if:
- Those Heart failure patient whose are in acute phase or planed for any immediate medical intervention
- Already participating in cardiac rehabilitation
- New York Heart Association (NYHA) Classification of HF class IV HF symptoms
- Co-existent other disease such as asthma/ COPD/interstitial lung disease.
- Symptomatic Second degree or third degree heart block.
- ECG with uncontrolled ventricular arrhythmia
- Limited Exercise ability due to neurologic or orthopedic impairments of the legs (will cross-check with 6 MWT)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Pakistan Railway Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Rawalpindi Institute of Cardiology
Rawalpindi, Punjab Province, 46000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad Iqbal Tariq, PhD*
Riphah International University
- STUDY CHAIR
Arshad Nawaz Malik, PhD
Riphah International University
- STUDY CHAIR
Shane Patman, PhD
University of Notre Dame Australia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Group allocation will be kept blinded to the assessor and to the treatment provider (trained physical therapist).
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2023
First Posted
September 13, 2023
Study Start
September 20, 2023
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share